CEDARHURST, N.Y., Nov. 23, 2022 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Centessa Pharmaceuticals plc (NasdaqGS: CNTA), if they purchased or otherwise acquired the Company’s securities between May 28, 2021 and June 1, 2022, inclusive (the “Class Period”) and/or purchased or otherwise acquired the Company’s American Depositary Shares (“ADSs”) pursuant to the Company’s May 2021 initial public offering (the “IPO”). Shareholders have until November 28, 2022 to file lead plaintiff applications in the securities class action lawsuit.
Shareholders are encouraged to contact us at https://kclasslaw.com/cases/securities/nasdaqgs-cnta/, by calling toll-free at 1-833-835-1495 or by email ([email protected]).
Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: [email protected]
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
https://kclasslaw.com
